NYSE:INO

Inovio Pharmaceuticals Stock Predictions

Healthcare > Biotechnology

Buy INO

*Your capital is at risk

$1.16

+0.0200 (+1.75%)

At Close: Jun 04, 2026

Currently predicting for Fri, 5 Jun 2026

INO Prediction Chart

INO Predictions History

Latest community submissions for INO.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
2poJeff Pro	Feb 11, 2020	$3.51 -91.37%	$3.39	X	96.46%	1
JS Pro	Feb 11, 2020	$3.03 -92.55%	$3.39	V	89.38%	0
TONYCORTES128879	Feb 11, 2020	Bearish	$3.39	V	—	0
JS Pro	Feb 10, 2020	$3.08 -92.62%	$3.48	V	88.51%	0
2poJeff Pro	Feb 10, 2020	$3.36 -91.95%	$3.48	V	96.55%	0
TONYCORTES128879	Feb 10, 2020	Bearish	$3.48	V	—	0
JS Pro	Feb 7, 2020	$3.23 -91.56%	$3.19	V	98.75%	2
TONYCORTES128879	Feb 7, 2020	Bearish	$3.19	V	—	1
Kailash Jayaraman @KailashJayaraman.138194	Feb 6, 2020	Bullish	$3.37	X	—	0
2poJeff Pro	Feb 6, 2020	$3.66 -90.95%	$3.37	V	91.39%	1

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for INO with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT INOVIO PHARMACEUTICALS

Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery o...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	4.43%	Jun 01
N NVRI $19.53	0.87%	May 20
RUN $12.83	15.51%	May 06
GLBE $31.61	4.05%	May 05
SAP $172.39	8.56%	May 05

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by